{
  "id": "0522367b231b4235",
  "title": "STAT+: 3 issues to watch in biopharma in 2026",
  "description": "A new year will bring new challenges for the pharmaceutical and biotech industries and policymakers.",
  "content": "A new year will bring new challenges for the pharmaceutical and biotech industries and policymakers.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/01/05/biopharma-2026-issues-to-watch-obesity-pills-patent-reform-340b-drugs/?utm_campaign=rss",
  "published_at": "2026-01-05T09:30:00+00:00",
  "fetched_at": "2026-01-06T00:23:36.488656+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "STAT+: 3 issues to watch in biopharma in 2026",
    "description": "A new year will bring new challenges for the pharmaceutical and biotech industries and policymakers.",
    "url": "https://www.statnews.com/pharmalot/2026/01/05/biopharma-2026-issues-to-watch-obesity-pills-patent-reform-340b-drugs/?utm_campaign=rss",
    "published": "2026-01-05T09:30:00+00:00",
    "source": "STAT"
  }
}